Today: 29 April 2026
BHP stock near 52-week high as copper opens 2026 higher; Jan. 20 production update looms
4 January 2026
1 min read

BHP stock near 52-week high as copper opens 2026 higher; Jan. 20 production update looms

NEW YORK, Jan 4, 2026, 16:04 ET — Market closed

  • BHP’s U.S.-listed shares finished Friday up 2.3%, closing near recent highs.
  • Copper and iron ore prices started 2026 firmer, keeping miners in focus. 
  • Next catalyst is BHP’s operational review on Jan. 20, followed by half-year results on Feb. 17. 

BHP Group Ltd’s U.S.-listed shares ended the first trading day of 2026 higher, as firmer metals prices helped lift sentiment into the first full week of January. The stock last traded at $61.76, up 2.3% from its prior close.

With U.S. markets shut on Sunday, attention shifts to what could move BHP when trading resumes on Monday. For investors, the stock is a proxy for the industrial-metals cycle at a time macro data and the U.S. dollar are back in the driver’s seat.

BHP has two near-term company dates on the calendar, giving traders a clear roadmap. The miner is due to publish its operational review for the half year ended Dec. 31, 2025 on Jan. 20, and report half-year results on Feb. 17, the company’s financial calendar shows. 

Commodity moves were supportive on Friday. Copper rose 0.8% to $12,522.50 a tonne on the London Metal Exchange, while iron ore futures in Singapore gained 0.2% to $105.60 a tonne, Bloomberg data showed. 

Currency traders are also setting the tone for metals-linked stocks. The dollar began 2026 firmer, and “it’s going to be a time to actually do a lot of assessment,” Juan Perez, director of trading at Monex USA, said as markets looked ahead to a data-heavy week.  Reuters

For BHP, the January production update is the first scheduled read on volumes and costs after the December quarter, alongside any commentary on demand in China, the biggest consumer of steelmaking raw materials. Investors will also be listening for signals on whether the company’s near-term guidance is holding.

On the technical side, BHP’s ADR — a U.S.-traded certificate representing shares in a foreign company — closed at $61.76 on Jan. 2, leaving it just below its recent high-water mark around $62. Data showed the stock’s 52-week high stands at $62.01, with about 2.06 million shares traded on Friday. 

A push through the $62 area would put fresh highs back in play, while a move back under $60 would highlight how quickly momentum can fade in a commodity-led tape. Traders often treat those round numbers as short-term support and resistance.

The risk for bulls is that metals prices turn lower just as the company approaches its update window. A firmer dollar, a wobble in China-linked demand expectations, or a surprise on costs can cut quickly into miner sentiment, particularly for stocks trading near their peaks.

The next concrete catalyst for BHP is its operational review scheduled for Jan. 20 in Melbourne, ahead of the Feb. 17 half-year results. 

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
SailPoint stock slides 6% into 2026 — here’s what investors watch before Monday
Previous Story

SailPoint stock slides 6% into 2026 — here’s what investors watch before Monday

Exxon Mobil stock (XOM) in focus as U.S. presses oil majors on Venezuela ahead of Monday open
Next Story

Exxon Mobil stock (XOM) in focus as U.S. presses oil majors on Venezuela ahead of Monday open

Go toTop